(Q37995646)

26 August 2017

title

Prebiopsy magnetic resonance spectroscopy and imaging in the diagnosis of prostate cancer (English)

1 reference

26 August 2017

1 reference

Virendra Kumar

1

1 reference

26 August 2017

Naranamangalam R Jagannathan

series ordinal

2

1 reference

26 August 2017

Sanjay Thulkar

series ordinal

3

1 reference

26 August 2017

Rajeev Kumar

series ordinal

4

1 reference

26 August 2017

publication date

21 March 2012

1 reference

International Journal of Urology

26 August 2017

published in

1 reference

26 August 2017

volume

19

1 reference

26 August 2017

issue

7

1 reference

26 August 2017

page(s)

602-613

1 reference

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Screening for prostate cancer: current recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

The prostate: MR imaging and spectroscopy. Present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Imaging localized prostate cancer: current approaches and new developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Dynamic contrast-enhanced magnetic resonance imaging in the evaluation of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Minimum apparent diffusion coefficient is significantly correlated with cellularity in medulloblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Diffusion-weighted imaging of mucinous carcinoma of the breast: evaluation of apparent diffusion coefficient and signal intensity in correlation with histologic findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Diffusion Tensor Magnetic Resonance Imaging of Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Diffusion-weighted imaging of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

In vivo diffusion tensor imaging of the human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Magnetization transfer in MRI: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Evaluation of the role of magnetization transfer imaging in prostate: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Mitochondrial function, zinc, and intermediary metabolism relationships in normal prostate and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Concepts of citrate production and secretion by prostate. 1. Metabolic relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Citrate in the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Role of magnetic resonance methods in the evaluation of prostate cancer: an Indian perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

The Clinical Value of Performing an MRI before Prostate Biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Apparent diffusion coefficient of the prostate in men prior to biopsy: determination of a cut-off value to predict malignancy of the peripheral zone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Combined prostate diffusion tensor imaging and dynamic contrast enhanced MRI at 3T--quantitative correlation with biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Three-dimensional 1H-magnetic resonance spectroscopy of the prostate in clinical practice: technique and results in patients with elevated prostate-specific antigen and negative or no previous prostate biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Design of a novel MRI compatible manipulator for image guided prostate interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Advancements in magnetic resonance-guided robotic interventions in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

MR-guided biopsy of the prostate: an overview of techniques and a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Accuracy validation for MRI-guided robotic prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Upgrading of Gleason score on radical prostatectomy specimen compared to the pre-operative needle core biopsy: an Indian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Potential of (1)H MR spectroscopic imaging to segregate patients who are likely to show malignancy of the peripheral zone of the prostate on biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Peripheral zone prostate cancer in patients with elevated PSA levels and low free-to-total PSA ratio: detection with MR imaging and MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Accuracy of MRI/MRSI-based transrectal ultrasound biopsy in peripheral and transition zones of the prostate gland in patients with prior negative biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.02995.X

10.1111/J.1442-2042.2012.02995.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference